Showing results (781-790 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|May 29, 2025
Rapid radiological response of leptomeningeal carcinosis and prolonged survival to encorafenib and binimetinib in BRAF-mutated melanomaGiacomo Corradi, Sara De Martino, Angela Rinaldi, et al.Anti-Cancer Drugs|November 2, 2025
Locoregional and symptomatic response to neoadjuvant dual HER2 blockade with chemotherapy in HER2-positive breast cancer: a pilot studyGurjeet Singh Chowdhary, Ankush Nayyar, Sridharan Vasudevan, et al.Anti-Cancer Drugs|November 3, 2025
Collagen I is the effective therapeutic target for treating desmoid tumorsYehyeong Lee, Yonghyo Kim, Chankyoung Lee, et al.Anti-Cancer Drugs|July 8, 2025
Distribution of side effects of anti-EGFR treatments in patients with metastatic colorectal cancer and evaluation of their relationship with survivalMert Erciyestepe, Okan Aydin, Sermin Dinc Sonusen, et al.Anti-Cancer Drugs|January 8, 2026
Efficacy and safety of fulvestrant combined with abemaciclib in patients with hormone receptor-positive advanced breast cancerLei Su, Yunyi Du, Jingyu Yao, et al.Anti-Cancer Drugs|January 8, 2026
Fibroblast growth factor receptor 2 mutation-guided targeted therapy with lenvatinib in sebaceous carcinoma of the external auditory canal: a case report and literature reviewRuGang Zhao, Qing Han, JuYi Wen, et al.Anti-Cancer Drugs|December 24, 2025
Clinical importance of the interactions between the TGF-β1/SMAD and NF-κB pathways in colorectal cancer and the study of the synergistic regulatory mechanism of the STAT3-mediated pathwayHuang Chao, Haosheng Liu, Weizeng ShenAnti-Cancer Drugs|December 23, 2025
Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivityUgur Ozberk, Selin Akturk Esen, Serhat Sekmek, et al.Anti-Cancer Drugs|April 25, 2025
9-Hexadecenoic acid inhibits the aggressiveness of gastric cancer via targeting PTPN1/FTH1 signalingXin Wang, Haiyan PengAnti-Cancer Drugs|April 25, 2025
A fatty acid metabolism-related gene signature can predict poor prognosis in gliomaChuanyu Li, Xinran Xue, Jiahui Kong, et al.Pageof 464